Evidence map›Paper›PMID 36255300›Full record

ArticleMicrobiology spectrum2022

Statistical Evaluation of Metaproteomics and 16S rRNA Amplicon Sequencing Techniques for Study of Gut Microbiota Establishment in Infants with Cystic Fibrosis.

Claudia Saralegui, Carmen García-Durán, Eduardo Romeu, María Luisa Hernáez-Sánchez, Ainhize Maruri, Natalia Bastón-Paz, Adelaida Lamas, Saioa Vicente, Estela Pérez-Ruiz, Isabel Delgado and 6 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Claudia Saralegui *Servicio de Microbiología, Hospital Universitario Ramón y Cajalgrid.411347.4 and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Carmen García-Durán *Departamento de Microbiología y Parasitología, Universidad Complutense de Madrid and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Eduardo RomeuUnidad de Proteómica, Universidad Complutense de Madrid, Madrid, Spain.
María Luisa Hernáez-SánchezUnidad de Proteómica, Universidad Complutense de Madrid, Madrid, Spain.
Ainhize MaruriServicio de Microbiología, Hospital Universitario Ramón y Cajalgrid.411347.4 and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Natalia Bastón-PazServicio de Microbiología, Hospital Universitario Ramón y Cajalgrid.411347.4 and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Adelaida LamasUnidad de Fibrosis Quística, Hospital Universitario Ramón y Cajalgrid.411347.4, Madrid, Spain.
Saioa VicenteUnidad de Fibrosis Quística, Hospital Universitario Ramón y Cajalgrid.411347.4, Madrid, Spain.
Estela Pérez-RuizUnidad de Fibrosis Quística, Hospital Regional Universitario de Málaga, Málaga, Spain.
Isabel DelgadoUnidad de Fibrosis Quística, Hospital Virgen del Rocío, Seville, Spain.
Carmen Luna-ParedesSección de Neumología y Alergia Infantil, Unidad Multidisciplinar Fibrosis Quística, Hospital Doce de Octubre, Madrid, Spain.
Juan de Dios CaballeroServicio de Microbiología, Hospital Universitario Ramón y Cajalgrid.411347.4 and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Javier ZamoraUnidad de Bioestadística, Hospital Universitario Ramón y Cajalgrid.411347.4 and Instituto Ramón y Cajal de Investigación Sanitaria and CIBERESP, Madrid, Spain.
Lucía MonteolivaDepartamento de Microbiología y Parasitología, Universidad Complutense de Madrid and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.ORCID 0000-0003-4949-0664
Concepción GilDepartamento de Microbiología y Parasitología, Universidad Complutense de Madrid and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.
Rosa Del CampoServicio de Microbiología, Hospital Universitario Ramón y Cajalgrid.411347.4 and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.ORCID 0000-0003-1147-7923
Centro de Investigación Biomédica en Red · ESUniversidad Complutense de Madrid · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESHospital Regional Universitario de Málaga · ESHospital Universitario 12 De Octubre · ESHospital Universitario Virgen del Rocío · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Newborn screening for cystic fibrosis (CF) can identify affected but asymptomatic infants. The selection of omic technique for gut microbiota study is crucial due to both the small amount of feces available and the low microorganism load. Our aims were to compare the agreement between 16S rRNA amplicon sequencing and metaproteomics by a robust statistical analysis, including both presence and abundance of taxa, to describe the sequential establishment of the gut microbiota during the first year of life in a small size sample (8 infants and 28 fecal samples). The taxonomic assignations by the two techniques were similar, whereas certain discrepancies were observed in the abundance detection, mostly the lower predicted relative abundance of

Indexed as

Cystic FibrosisGastrointestinal MicrobiomeMicrobiotaBacillotaBacteriaEubacterialesFecesHumansInfantInfant, NewbornRNA, Ribosomal, 16SRNA, Ribosomal, 16Samplicon sequencingBland-Altman testcystic fibrosisgut microbiota establishmentmetaproteomicsRuminococcus gnavus

Identifiers

PMID36255300
PMCPMC9784762
OpenAlexW4306733108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.